Description
我们与国内外500余家国际医疗机构以及每年2000个专业医学论坛和学术会议建立了长期友好的协作关系。
目前我们拥有全球的国际医学学术会议视频及文献库，国际前沿的医管学院及临床学院的视频课程、国内外权威级会议论坛直播及回放、数百万国际专家最新临床研究及实践等视频资源国内外医、期刊、临床指南、临床案例等专业的医学内容。
最前沿的学术引领和便捷的交流平台全面赋能中国医生。
目前我们拥有全球的国际医学学术会议视频及文献库，国际前沿的医管学院及临床学院的视频课程、国内外权威级会议论坛直播及回放、数百万国际专家最新临床研究及实践等视频资源国内外医、期刊、临床指南、临床案例等专业的医学内容。
最前沿的学术引领和便捷的交流平台全面赋能中国医生。
Screenshots
医讯邦 FAQ
-
Is 医讯邦 free?
Yes, 医讯邦 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 医讯邦 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 医讯邦 cost?
医讯邦 is free.
-
What is 医讯邦 revenue?
To get estimated revenue of 医讯邦 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Philippines yet.
Ratings History
医讯邦 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
医讯邦 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
药先知
|
Unlock
|
Unlock
|
0
|
|
10 months ago | |
全病程管理
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
CHINA VALVE(HANGZHOU)
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
医搜-感知医学脉搏助力临床决策
为传递医学信息而生
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
民达·尚医汇
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
乐问健康
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
医介
血管领域医生学习交流平台
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
每日医线
每日|医线|医生|医美|健康
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
CCAC暨SCI
|
Unlock
|
Unlock
|
0
|
|
4 years ago | |
院长日报
|
Unlock
|
Unlock
|
0
|
|
2 years ago |
医讯邦 Installs
Last 30 days
医讯邦 Revenue
Last 30 days医讯邦 Revenue and Downloads
Gain valuable insights into 医讯邦 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English, Chinese
- Recent release
- 3.4.5 (1 week ago )
- Released on
- Dec 15, 2021 (3 years ago )
- Also available in
- China , Malaysia , Philippines , Peru , New Zealand , Nepal , Norway , Netherlands , Nigeria , Pakistan , Mexico , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Italy , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Armenia , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.